These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37617838)

  • 21. Late-onset agoraphobia: general population incidence and evidence for a clinical subtype.
    Ritchie K; Norton J; Mann A; Carrière I; Ancelin ML
    Am J Psychiatry; 2013 Jul; 170(7):790-8. PubMed ID: 23820832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An admixture analysis of age of onset in agoraphobia.
    Tibi L; van Oppen P; Aderka IM; van Balkom AJ; Batelaan NM; Spinhoven P; Penninx BW; Anholt GE
    J Affect Disord; 2015 Jul; 180():112-5. PubMed ID: 25898330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the clinical utility of agoraphobia in the context of panic disorder.
    Schmidt NB; Cromer KR
    Depress Anxiety; 2008; 25(2):158-66. PubMed ID: 17351905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dexamethasone suppression test in panic disorder and agoraphobia.
    Curtis GC; Cameron OG; Nesse RM
    Am J Psychiatry; 1982 Aug; 139(8):1043-6. PubMed ID: 7091428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Panic disorder and agoraphobia: an overview and commentary on DSM-5 changes.
    Asmundson GJ; Taylor S; Smits JA
    Depress Anxiety; 2014 Jun; 31(6):480-6. PubMed ID: 24865357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing the severity of panic disorder and agoraphobia: validity, reliability and objectivity of the Turkish translation of the Panic and Agoraphobia Scale (P&A).
    Tural U; Fidane H; Alkin T; Bandelow B
    J Anxiety Disord; 2002; 16(3):331-40. PubMed ID: 12214818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for the onset of Diagnostic Interview Schedule/DSM-III agoraphobia in a prospective, population-based study.
    Eaton WW; Keyl PM
    Arch Gen Psychiatry; 1990 Sep; 47(9):819-24. PubMed ID: 2393340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A taxometric investigation of agoraphobia in a clinical and a community sample.
    Slade T; Grisham JR
    J Anxiety Disord; 2009 Aug; 23(6):799-805. PubMed ID: 19369029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Panic disorder with and without agoraphobia: comorbidity within a half-year of the onset of panic disorder.
    Kikuchi M; Komuro R; Oka H; Kidani T; Hanaoka A; Koshino Y
    Psychiatry Clin Neurosci; 2005 Dec; 59(6):639-43. PubMed ID: 16401237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agoraphobia is a disease: a tribute to Sir Martin Roth.
    Fava GA; Rafanelli C; Tossani E; Grandi S
    Psychother Psychosom; 2008; 77(3):133-8. PubMed ID: 18277059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship of agoraphobia and panic in a community sample of adolescents and young adults.
    Wittchen HU; Reed V; Kessler RC
    Arch Gen Psychiatry; 1998 Nov; 55(11):1017-24. PubMed ID: 9819071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Agoraphobia with panic disorder combined with depression].
    Statsenko OA; Usov GM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(5. Vyp. 2):49-54. PubMed ID: 34405657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of the Panic and Agoraphobia Scale in a clinical trial.
    Bandelow B; Brunner E; Broocks A; Beinroth D; Hajak G; Pralle L; Rüther E
    Psychiatry Res; 1998 Jan; 77(1):43-9. PubMed ID: 10710174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the efficacy of treatments for panic disorder and agoraphobia. I. Methodological problems.
    Bandelow B; Hajak G; Holzrichter S; Kunert HJ; Rüther E
    Int Clin Psychopharmacol; 1995 Jun; 10(2):83-93. PubMed ID: 7673660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A contribution of fluorescent lighting to agoraphobia.
    Hazell J; Wilkins AJ
    Psychol Med; 1990 Aug; 20(3):591-6. PubMed ID: 2236367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive mediation of clinical improvement after intensive exposure therapy of agoraphobia and social phobia.
    Vögele C; Ehlers A; Meyer AH; Frank M; Hahlweg K; Margraf J
    Depress Anxiety; 2010 Mar; 27(3):294-301. PubMed ID: 20037922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of personality disorders on response to cognitive behavioral therapy of panic disorder with agoraphobia].
    Marchand A; Wapler M
    Can J Psychiatry; 1993 Apr; 38(3):163-6. PubMed ID: 8500066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anxiety, panic and phobic disorders: an overview.
    Roth M; Argyle N
    J Psychiatr Res; 1988; 22 Suppl 1():33-54. PubMed ID: 3050059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychometric properties of the mobility inventory for agoraphobia: convergent, discriminant, and criterion-related validity.
    Chambless DL; Sharpless BA; Rodriguez D; McCarthy KS; Milrod BL; Khalsa SR; Barber JP
    Behav Ther; 2011 Dec; 42(4):689-99. PubMed ID: 22035997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Panic attacks, hypochondriasis, and agoraphobia: a self-psychology formulation.
    Diamond DB
    Am J Psychother; 1985 Jan; 39(1):114-25. PubMed ID: 3985222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.